Interferon-γ ELISPOT as a biomarker of treatment efficacy in latent tuberculosis infection: a clinical trial (Q44602188)

4 December 2017

Interferon-γ ELISPOT as a biomarker of treatment efficacy in latent tuberculosis infection: a clinical trial (English)

1 reference

4 December 2017

0 references

1 reference

1 reference

13

1 reference

4 December 2017

Patrick K Owiafe

7

0 references

Richard Adebayo Adegbola

14

object named as

Richard A Adegbola

1 reference

4 December 2017

Ifedayo M Adetifa

1

1 reference

4 December 2017

Martin O C Ota

2

1 reference

4 December 2017

David J Jeffries

3

1 reference

4 December 2017

Moses D Lugos

4

1 reference

4 December 2017

Abdulrahman S Hammond

5

1 reference

4 December 2017

Nicholas J Battersby

6

1 reference

4 December 2017

Simon D Donkor

8

1 reference

4 December 2017

Martin Antonio

9

1 reference

4 December 2017

Hannah B Ibanga

10

1 reference

4 December 2017

Roger H Brookes

11

1 reference

4 December 2017

Peter Aka

12

1 reference

4 December 2017

Philip C Hill

15

1 reference

4 December 2017

language of work or name

English

0 references

publication date

6 December 2012

1 reference

American Journal of Respiratory and Critical Care Medicine

4 December 2017

1 reference

4 December 2017

187

1 reference

4 December 2017

4

1 reference

4 December 2017

439-445

1 reference

Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research.

4 December 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201208-1352OC

Decay kinetics of an interferon gamma release assay with anti-tuberculosis therapy in newly diagnosed tuberculosis cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201208-1352OC

Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201208-1352OC

Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201208-1352OC

Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201208-1352OC

Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201208-1352OC

Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201208-1352OC

Rapid effector function in CD8+ memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201208-1352OC

Point-of-care Arkansas method for measuring adherence to treatment with isoniazid

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201208-1352OC

Sub-Saharan African coding sequence variation and haplotype diversity at the NAT2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201208-1352OC

Immunological biomarkers of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201208-1352OC

In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-gamma T cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201208-1352OC

Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201208-1352OC

Correlation of mycobacterium tuberculosis specific and non-specific quantitative Th1 T-cell responses with bacillary load in a high burden setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201208-1352OC

Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201208-1352OC

Commercial interferon gamma release assays compared to the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection in childhood contacts in the Gambia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201208-1352OC

Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201208-1352OC

Relevance of latent TB infection in areas of high TB prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201208-1352OC

Thibela TB: design and methods of a cluster randomised trial of the effect of community-wide isoniazid preventive therapy on tuberculosis amongst gold miners in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201208-1352OC

Tuberculosis case-contact research in endemic tropical settings: design, conduct, and relevance to other infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201208-1352OC

Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201208-1352OC

Dynamic Antigen-specific T-Cell Responses after Point-Source Exposure toMycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201208-1352OC

Enzyme-Linked Immunospot Assay Responses to Early Secretory Antigenic Target 6, Culture Filtrate Protein 10, and Purified Protein Derivative among Children with Tuberculosis: Implications for Diagnosis and Monitoring of Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201208-1352OC

10.1164/RCCM.201208-1352OC

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference